News
Search here results
search-total-matching8search-total-matching- How SARS-CoV-2 is changed by antiviral treatments focus of new UCL study | UCL News - UCL – University College London
- New state-of-the-art centre for immune disease opens | UCL News - UCL – University College London
- Novel UCL developed cancer drug to be trialled in humans | UCL News - UCL – University College London
- Kidney failure patients among worst affected during COVID-19 | UCL News - UCL – University College London
- Immunity experts to move into state-of-the-art facilities | UCL News - UCL – University College London
- Antiviral drugs trialled in the early stages of COVID-19 | UCL News - UCL – University College London
- Immunotherapy biomarker discovery could benefit thousands with Type 1 diabetes | UCL News - UCL – University College London
- Two UCL academics among WEF Young Scientists | UCL News - UCL – University College London
Please enable JavaScript to use this page or visit this page for a non javascript version.